KUALA LUMPUR, Jan 10 (Bernama) -- Fortrea announced an industry partnership with founding members Veeva Systems Inc, a cloud solutions provider for the global life sciences industry, and Advarra, a clinical research technology provider for clinical research investigator sites and sponsors.
According to the global contract research organisation (CRO) in a statement, the partnership is to deliver an integrated patient- and site-centric solution that streamlines the clinical trial experience.
Fortrea Chief Operating Officer and President of Clinical Services, Mark Morais said working with industry-leading partners and founding members, the company has taken action to remove complexities so it can address the pain points of sites and patients as well as make a difference.
“We are leveraging our unique vantage point in the industry that enables us to layer our expertise over the tech and data ecosystems from best-in-class partners, adding to our alliance as we go, to dramatically simplify the experience for patients, sites and sponsors,” he added.
In an industry faced with complex challenges to clinical trial execution, Fortrea is establishing an alliance of industry partners, beginning with founding members, Veeva and Advarra, to tackle some of these challenges head-on.
For sites, the partnership is set to deliver a cloud-based, simplified sign-on experience for Fortrea-run studies; access to study technologies through a single dashboard; and a unified environment with a single repository for study documents and records.
Meanwhile, for patients, the solution is being designed to offer easy-to-access, step-by-step, visit-by-visit support and education throughout a patient’s trial journey; a simplified user experience through a single platform; and self-referral functionality to search and find studies in their disease area of interest, among others.
The three companies are partnering to offer a seamless, unified technology solution that integrates best-in-class technologies and leverages Fortrea’s process expertise, which will help ease the administrative burden for patients and sites, as well as increase the accessibility of clinical trials for the public.
-- BERNAMA
No comments:
Post a Comment